Literature DB >> 19254587

Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndrome.

Ahinoam Lev-Sagie1, Diana Prus, Iara M Linhares, Yuval Lavy, William J Ledger, Steven S Witkin.   

Abstract

OBJECTIVE: Patients with vulvar vestibulitis syndrome (VVS) and control subjects were tested for a polymorphism in the gene coding for the NALP3 component of inflammasomes, cytoplasmic structures regulating interleukin (IL)-1beta production. STUDY
DESIGN: DNA from 143 women with VVS and 182 control women were tested for a length polymorphism in intron 4 of the gene (CIAS1) that codes for NALP3. Vestibular tissue was examined for NALP3 expression. Whole blood cultures were tested for Candida albicans-induced IL-1beta production.
RESULTS: The allele 12 frequency was higher in control subjects than in the patients with VVS (P = .02). Among patients with VVS and a self-reported history of recurrent vulvovaginal candidiasis (RVVC), the allele 7 frequency was 43.9% as compared with 30.8% in patients with no history of RVVC and 26.9% in control women (P = .035 vs other patients and .001 vs control subjects). NALP3 was identified in vestibular tissue. C albicans-induced IL-1beta production was reduced in samples from women with the 7,7 genotype (P = .030).
CONCLUSION: Polymorphism in the CIAS1 gene may play a central role in the triggering of VVS in a subset of patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254587     DOI: 10.1016/j.ajog.2008.10.039

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  44 in total

Review 1.  Human genetic susceptibility to Candida infections.

Authors:  Theo S Plantinga; Melissa D Johnson; William K Scott; Leo A B Joosten; Jos W M van der Meer; John R Perfect; Bart Jan Kullberg; Mihai G Netea
Journal:  Med Mycol       Date:  2012-06-04       Impact factor: 4.076

Review 2.  The mycobiota: interactions between commensal fungi and the host immune system.

Authors:  David M Underhill; Iliyan D Iliev
Journal:  Nat Rev Immunol       Date:  2014-06       Impact factor: 53.106

Review 3.  A psychosocial approach to female genital pain.

Authors:  Marieke Dewitte; Charmaine Borg; Lior Lowenstein
Journal:  Nat Rev Urol       Date:  2017-11-28       Impact factor: 14.432

Review 4.  Genetic and molecular basis of inflammasome-mediated disease.

Authors:  Hal M Hoffman; Susannah D Brydges
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

Review 5.  The inflammasomes in health and disease: from genetics to molecular mechanisms of autoinflammation and beyond.

Authors:  Cristina Conforti-Andreoni; Paola Ricciardi-Castagnoli; Alessandra Mortellaro
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

6.  Genetic basis for recurrent vulvo-vaginal candidiasis.

Authors:  Martin Jaeger; Theo S Plantinga; Leo A B Joosten; Bart-Jan Kullberg; Mihai G Netea
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

7.  Progresses in vaginal microflora physiology and implications for bacterial vaginosis and candidiasis.

Authors:  Gary Ventolini
Journal:  Womens Health (Lond)       Date:  2016-05-24

8.  The mycobiota of the human body: a spark can start a prairie fire.

Authors:  Di Zhang; Ying Wang; Sunan Shen; Yayi Hou; Yugen Chen; Tingting Wang
Journal:  Gut Microbes       Date:  2020-03-09

9.  Interleukin 1α Is Critical for Resistance against Highly Virulent Aspergillus fumigatus Isolates.

Authors:  Alayna K Caffrey-Carr; Caitlin H Kowalski; Sarah R Beattie; Nathan A Blaseg; Chanell R Upshaw; Arsa Thammahong; Hannah E Lust; Yi-Wei Tang; Tobias M Hohl; Robert A Cramer; Joshua J Obar
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

10.  The bacterial microbiome in paired vaginal and vestibular samples from women with vulvar vestibulitis syndrome.

Authors:  Aswathi Jayaram; Steven S Witkin; Xia Zhou; Celeste J Brown; Gustavo E Rey; Iara M Linhares; William J Ledger; Larry J Forney
Journal:  Pathog Dis       Date:  2014-07-10       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.